Literature DB >> 20882896

Immunohistochemical expression of granzyme B and vascular endothelial growth factor (VEGF) in normal uterine cervices and low and high grade squamous intraepithelial lesions.

P N Belfort-Mattos1, G R A Focchi, N M G Speck, N S A Taha, C R N Carvalho, J C L Ribalta.   

Abstract

PURPOSE: This study aimed to evaluate the immunoexpression of granzyme B and vascular endothelial growth factor (VEGF) in the variants of cervical squamous intraepithelial neoplasia.
METHODS: Granzyme B immunohistochemical expression was studied in the epithelium, stroma and in both the epithelium + stroma of 142 fragments of uterine cervix; there were 34 grade 1 cervical intraepithelial neoplasias (CIN 1), 36 grade 2 cervical intraepithelial neoplasias (CIN 2), 33 grade 3 cervical intraepithelial neoplasias (CIN 3) and 39 uterine cervix fragments without abnormalities - control group. Immunoexpression of VEGF was studied in 160 uterine cervix fragments, with 43 grade 1 cervical intraepithelial neoplasias (CIN 1), 33 grade 2 cervical intraepithelial neoplasias (CIN 2), 31 grade 3 cervical intraepithelial neoplasias (CIN 3) and 53 uterine cervix fragments without abnormalities--control group.
RESULTS: In the stroma, immunoexpression of granzyme B in grade 1 cervical intraepithelial neoplasias was smaller than in grade 3 cervical intraepithelial neoplasias. High VEGF immunoexpression was found in grade 3 cervical intraepithelial neoplasias while it was low in grade 1 cervical intraepithelial neoplasias and in the control group.
CONCLUSION: The higher the severity of the cervical intraepithelial lesion, the higher the immunoexpression of granzyme B. A progressive increase in VEGF immunoexpression was found in the intense grade, according to the severity of the cervical intraepithelial neoplasia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20882896

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma.

Authors:  Arshad H Rahmani; Ali Yousif Babiker; Mohammed A Alsahli; Saleh A Almatroodi; Nazik Elmalaika O S Husain
Journal:  Open Access Maced J Med Sci       Date:  2018-02-10

Review 2.  Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis.

Authors:  Francesca Velotti; Ilaria Barchetta; Flavia Agata Cimini; Maria Gisella Cavallo
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

3.  Immunohistochemical Expression of VEGF and Podoplanin in Uterine Cervical Squamous Intraepithelial Lesions.

Authors:  Patrícia Napoli Belfort-Mattos; Gustavo Rubino de Azevedo Focchi; Julisa Chamorro Lascasas Ribalta; Tatiana Megale De Lima; Carmen Regina Nogueira Carvalho; Fernanda Kesselring Tso; Neila Maria De Góis Speck
Journal:  Dis Markers       Date:  2016-05-23       Impact factor: 3.434

4.  Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells.

Authors:  Donatella D'Eliseo; Giuliana Di Rocco; Rossella Loria; Silvia Soddu; Angela Santoni; Francesca Velotti
Journal:  J Exp Clin Cancer Res       Date:  2016-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.